相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Potent Synergistic Interactions between Lopinavir and Azole Antifungal Drugs against Emerging Multidrug-Resistant Candida auris
Hassan E. Eldesouky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Broad-Spectrum Antifungal Agents: Fluorinated Aryl- and Heteroaryl-Substituted Hydrazones
Nishad Thamban Chandrika et al.
CHEMMEDCHEM (2021)
Antifungal and anti-biofilm effects of 6-shogaol againstCandida auris
H. -R. Kim et al.
JOURNAL OF APPLIED MICROBIOLOGY (2021)
A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vitro Activity against Candida auris and Other Clinically Relevant Fungal Isolates
Sherman Chu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking
Miao Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Farnesol increases the activity of echinocandins against Candida auris biofilms
Fruzsina Nagy et al.
MEDICAL MYCOLOGY (2020)
Sertraline as a promising antifungal agent: inhibition of growth and biofilm of Candida auris with special focus on the mechanism of action in vitro
M. Gowri et al.
JOURNAL OF APPLIED MICROBIOLOGY (2020)
Inhibition of Candida auris Biofilm Formation on Medical and Environmental Surfaces by Silver Nanoparticles
Humberto H. Lara et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
In Vitro Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak
Brittany O'Brien et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In Vitro Antifungal Susceptibility of the Emerging Multidrug-Resistant Pathogen Candida auris to Miltefosine Alone and in Combination with Amphotericin B
Yongqin Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method
Marie Helleberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents
Maiken Cavling Arendrup et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates
Marhiah C. Montoya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose-Based Hydrogels for Wound Dressing Applications
Abhishek Gupta et al.
BIOMACROMOLECULES (2020)
Oxadiazolylthiazoles as novel and selective antifungal agents
Mohamed Hagras et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
Alan Talevi et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains
Francesco Orofino et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Pan-resistant Candida auris isolates from the outbreak in New York are susceptible to ibrexafungerp (a glucan synthase inhibitor)
Y. C. Zhu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Colistin interacts synergistically with echinocandins against Candida auris
A. L. Bidaud et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Distorted Gold(I)-Phosphine Complexes as Antifungal Agents
Emily K. Dennis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A Cerberus-Inspired Anti-Infective Multicomponent Gatekeeper Hydrogel against Infections with the Emerging Superbug Yeast Candida auris
Dennis Kubiczek et al.
MACROMOLECULAR BIOSCIENCE (2020)
Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?
Raquel Sabino et al.
MICROORGANISMS (2020)
Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris
Siham Shaban et al.
SCIENTIFIC REPORTS (2020)
Antifungal evaluation of traditional herbal monomers and their potential for inducing cell wall remodeling in Candida albicans and Candida auris
Juanjuan Liu et al.
BIOFOULING (2020)
Multidrug-resistant Candida auris: an epidemiological review
Arunaloke Chakrabarti et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)
Facile Route of Fabricating Long-Term Microbicidal Silver Nanoparticle Clusters against Shiga Toxin-Producing Escherichia coli O157:H7 and Candida auris
Sheeana Gangadoo et al.
COATINGS (2020)
Inactivation of the multi-drug-resistant pathogen Candida auris using ultraviolet germicidal irradiation
A. R. Lemons et al.
JOURNAL OF HOSPITAL INFECTION (2020)
Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species
Hassan E. Eldesouky et al.
SCIENTIFIC REPORTS (2020)
Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities
Hassan E. Eldesouky et al.
SCIENTIFIC REPORTS (2020)
In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris
Fruzsina Nagy et al.
FRONTIERS IN MICROBIOLOGY (2020)
Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds
Martin van Eijk et al.
MEDICAL MYCOLOGY (2020)
Essential Oil-Based Design and Development of Novel Anti-Candida Azoles Formulation
Rania Hamdy et al.
MOLECULES (2020)
Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic Candida Species
Nicole M. Revie et al.
MSPHERE (2020)
Antifungal Activity of Gepinacin Scaffold Glycosylphosphatidylinositol Anchor Biosynthesis Inhibitors with Improved Metabolic Stability
Sean D. Liston et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model
Lais Salomao Arias et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Efficacy of Ibrexafungerp (SCY-078) Against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model
M Ghannoum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Manogepix (APX001A) In Vitro Activity against Candida auris: Head-to-Head Comparison of EUCAST and CLSI MICs
Maiken Cavling Arendrup et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris
Rodnei Dennis Rossoni et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris
Thayna Lopes Barreto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Derivates of the Antifungal Peptide Cm-p5 Inhibit Development ofCandida aurisBiofilms In Vitro
Dennis Kubiczek et al.
ANTIBIOTICS-BASEL (2020)
Bismuth Nanoantibiotics Display Anticandidal Activity and Disrupt the Biofilm and Cell Morphology of the Emergent Pathogenic YeastCandida auris
Roberto Vazquez-Munoz et al.
ANTIBIOTICS-BASEL (2020)
NOCandida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal PathogenCandida auris
Levi G. Cleare et al.
JOURNAL OF FUNGI (2020)
In Vitro Activity of Manogepix against Multidrug-Resistant and Panresistant Candida auris from the New York Outbreak
YanChun Zhu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris
Hoang N. H. Tran et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Herbicides That Target Acetohydroxyacid Synthase Are Potent Inhibitors of the Growth of Drug-Resistant Candida auris
Kylie A. Agnew-Francis et al.
ACS INFECTIOUS DISEASES (2020)
α-Iodonitroalkenes as Potential Antifungal and Antitubercular Agents
Rambabu Pamarthi et al.
CHEMISTRYSELECT (2020)
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections
Mahmoud Ghannoum et al.
ANTIBIOTICS-BASEL (2020)
A marine microbiome antifungal targets urgent-threat drug-resistant fungi
Fan Zhang et al.
SCIENCE (2020)
Novel 2-Aryloxazoline Compounds Exhibit an Inhibitory Effect on Candida spp., Including Antifungal-Resistant Isolates
Luis M. Z. Argomedo et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris
Kali R. Iyer et al.
NATURE COMMUNICATIONS (2020)
In vitro synergy of isavuconazole in combination with colistin against Candida auris
Patrick Schwarz et al.
SCIENTIFIC REPORTS (2020)
Broad-spectrum antifungal activities and mechanism of drimane sesquiterpenoids
Edruce Edouarzin et al.
MICROBIAL CELL (2020)
Synthesis of new pyrazolo[5,1-c][1,2,4]triazines with antifungal and antibiofilm activities
Salah A. Al-Trawneh et al.
CHEMICAL PAPERS (2020)
Clinical Outcomes of Patients Treated for Candida auris Infections in a Multisite Health System, Illinois, USA
Kellie Arensman et al.
EMERGING INFECTIOUS DISEASES (2020)
Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of Candida auris and displays potent synergistic interactions with azole drugs
Hassan E. Eldesouky et al.
VIRULENCE (2020)
Antifungal activity of octenidine dihydrochloride and ultraviolet-C light against multidrug-resistant Candida auris
P. Ponnachan et al.
JOURNAL OF HOSPITAL INFECTION (2019)
Phenotypic switching in newly emerged multidrug-resistant pathogen Candida auris
Meghan L. Bentz et al.
MEDICAL MYCOLOGY (2019)
In Vitro Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp.
G. Tetz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Killing of Candida auris by UV-C: Importance of exposure time and distance
Theun de Groot et al.
MYCOSES (2019)
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016
Michael A. Pfaller et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Resistance of Candida to azoles and echinocandins worldwide
K. E. Pristov et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris
Haroldo Cesar de Oliveira et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
The efficacy of pulsed-xenon ultraviolet light technology on Candida auris
Caroline Maslo et al.
BMC INFECTIOUS DISEASES (2019)
In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris
Shivaprakash M. Rudramurthy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Probiotics as antifungal agents: Experimental confirmation and future prospects
Janet Cheruiyot Kosgey et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2019)
On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds
Arturo Casadevall et al.
MBIO (2019)
Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen
Caroline Dal Mas et al.
BIOMOLECULES (2019)
Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae
Zoltan Toth et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Candida auris outbreak: Mortality, interventions and cost of sustaining control
Surabhi K. Taori et al.
JOURNAL OF INFECTION (2019)
In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species
Shahram Mahmoudi et al.
MYCOPATHOLOGIA (2019)
The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection
Shakti Singh et al.
PLOS PATHOGENS (2019)
In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism
A. L. Bidaud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Probiotic Yeasts Inhibit Virulence of Non-albicans Candida Species
Lohith Kunyeit et al.
MBIO (2019)
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates In Vitro and In Vivo Activity against Candida auris
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal Activity
Fidel E. Morales Vicente et al.
ACS OMEGA (2019)
Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen
Jaroslava Dekkerova et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Global epidemiology of emerging Candida auris
Johanna Rhodes et al.
CURRENT OPINION IN MICROBIOLOGY (2019)
Identification of a Phenylthiazole Small Molecule with Dual Antifungal and Antibiofilm Activity Against Candida albicans and Candida auris
Haroon Mohammad et al.
SCIENTIFIC REPORTS (2019)
Management of Patients with Candida auris Fungemia at Community Hospital, Brooklyn, New York, USA, 2016-2018
Jenny YeiSol Park et al.
EMERGING INFECTIOUS DISEASES (2019)
On the Origins of a Species: What Might Explain the Rise of Candida auris?
Brendan R. Jackson et al.
JOURNAL OF FUNGI (2019)
Potential Fifth Clade of Candida auris, Iran, 2018
Nancy A. Chow et al.
EMERGING INFECTIOUS DISEASES (2019)
Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box
Gina Wall et al.
JOURNAL OF FUNGI (2019)
Synthesis of Superparamagnetic Iron Oxide Nanoparticles Stabilized by Biocompatible Supramolecular β-Cyclodextrin for Biomedical Applications
Sherin Philip et al.
MATERIALS TODAY-PROCEEDINGS (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Relative Resistance of the Emerging Fungal Pathogen Candida auris and Other Candida Species to Killing by Ultraviolet Light
Jennifer L. Cadnum et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2018)
Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus
Nathan P. Wiederhold et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Fungicidal Potency and Mechanisms of theta-Defensins against Multidrug-Resistant Candida Species
Virginia Basso et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model
Miao Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Significantly Improved Pharmacokinetics Enhances In Vivo Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis
Yanan Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris
Christopher L. Hager et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris
Elizabeth L. Berkow et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Candida auris in contemporary mycology labs: A few practical tricks to identify it reliably according to one recent French experience
G. Desoubeaux et al.
JOURNAL DE MYCOLOGIE MEDICALE (2018)
The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis
E. P. Garvey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms
Marjan M. Hashemi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model
Christopher L. Hager et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice
Timothy J. Break et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Surface disinfection challenges for Candida auris: an in-vitro study
R. Kean et al.
JOURNAL OF HOSPITAL INFECTION (2018)
The first isolate of Candida auris in China: clinical and biological aspects
Xiaojuan Wang et al.
EMERGING MICROBES & INFECTIONS (2018)
Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model
Alexander J. Lepak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development
Gina Wall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
APX001A In Vitro Activity against Contemporary Blood Isolates and Candida auris Determined by the EUCAST Reference Method
Maiken Cavling Arendrup et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris
Hassan E. Eldesouky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Activity of novel antifungal compound APX001A against a large collection of Candida auris
Elizabeth L. Berkow et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
A phenotypic small-molecule screen identifies halogenated salicylanilides as inhibitors of fungal morphogenesis, biofilm formation and host cell invasion
Carlos Garcia et al.
SCIENTIFIC REPORTS (2018)
The mycoparasitic yeast Saccharomycopsis schoenii predates and kills multi-drug resistant Candida auris
Klara Junker et al.
SCIENTIFIC REPORTS (2018)
Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey
Nancy A. Chow et al.
LANCET INFECTIOUS DISEASES (2018)
Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species
Jose F. Munoz et al.
NATURE COMMUNICATIONS (2018)
Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch
Huizhen Yue et al.
EMERGING MICROBES & INFECTIONS (2018)
Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
Zeinab Mamouei et al.
MSPHERE (2018)
Hog1 Regulates Stress Tolerance and Virulence in the Emerging Fungal Pathogen Candida auris
Alison M. Day et al.
MSPHERE (2018)
Evaluation of Antifungal Efficacy of Three New Cyclic Lipopeptides of the Class Bacillomycin from Bacillus subtilis RLID 12.1
Ramya Ramachandran et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses
Ruvini U. Pathirana et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant FungusUnited States, May 2013-August 2016 (Reprinted from vol 65, pg 1234-1237, 2016)
S. Vallabhaneni et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Emergence of Candida auris: An International Call to Arms
Cornelius J. Clancy et al.
CLINICAL INFECTIOUS DISEASES (2017)
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Shawn R. Lockhart et al.
CLINICAL INFECTIOUS DISEASES (2017)
Drug development challenges and strategies to address emerging and resistant fungal pathogens
Matthew W. McCarthy et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Effectiveness of Disinfectants Against Candida auris and Other Candida Species
Jennifer L. Cadnum et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)
Candida auris: An emerging multidrug-resistant pathogen
David Sears et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Nosocomial fungemia by Candida auris: First four reported cases in continental Europe
Alba Cecilia Ruiz Gaitan et al.
REVISTA IBEROAMERICANA DE MICOLOGIA (2017)
In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris
Hamed Fakhim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In Vitro Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris
Elizabeth L. Berkow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation
Emily Larkin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Necrotrophic Mycoparasites and Their Genomes
Magnus Karlsson et al.
MICROBIOLOGY SPECTRUM (2017)
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
Leighann Sherry et al.
EMERGING INFECTIOUS DISEASES (2017)
The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata
Nathan P. Wiederhold et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
T-2307, a novel arylamidine, is transported into Candida albicans nby a high-affinity spermine and spermidine carrier regulated by Agp2
Hiroshi Nishikawa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia
Belinda Calvo et al.
JOURNAL OF INFECTION (2016)
Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris
Sharanya Chatterjee et al.
BMC GENOMICS (2015)
Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae)
Carlos Lopez-Abarrategui et al.
FASEB JOURNAL (2015)
Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis
Dharmendra Kumar et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2015)
The Novel Arylamidine T-2307 Maintains In Vitro and In Vivo Activity against Echinocandin-Resistant Candida albicans
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Incidence, characteristics and outcome of ICU-acquired candidemia in India
Arunaloke Chakrabarti et al.
INTENSIVE CARE MEDICINE (2015)
Candida auris Candidemia in Kuwait, 2014
Maha Emara et al.
EMERGING INFECTIOUS DISEASES (2015)
Interplay between Candida albicans and the Antimicrobial Peptide Armory
Marc Swidergall et al.
EUKARYOTIC CELL (2014)
Multidrug-resistant endemic clonal strain of Candida auris in India
A. Chowdhary et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Antifungal Plant Defensins: Mechanisms of Action and Production
Kim Vriens et al.
MOLECULES (2014)
Defensins: antifungal lessons from eukaryotes
Patricia M. Silva et al.
FRONTIERS IN MICROBIOLOGY (2014)
Candida auris-Associated Candidemia, South Africa
Rindidzani E. Magobo et al.
EMERGING INFECTIOUS DISEASES (2014)
Candida albicans and Non-C. albicans Candida Species: Comparison of Biofilm Production and Metabolic Activity in Biofilms, and Putative Virulence Properties of Isolates from Hospital Environments and Infections
A. V. Ferreira et al.
MYCOPATHOLOGIA (2013)
Commercialization of antifungal peptides
Vanessa M. S. Duncan et al.
FUNGAL BIOLOGY REVIEWS (2013)
New Clonal Strain of Candida auris, Delhi, India
Anuradha Chowdhary et al.
EMERGING INFECTIOUS DISEASES (2013)
T-2307 Causes Collapse of Mitochondrial Membrane Potential in Yeast
Tatsuya Shibata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Use of Antimicrobial Peptides Against Microbial Biofilms: Advantages and Limits
Giovanna Batoni et al.
CURRENT MEDICINAL CHEMISTRY (2011)
First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
Wee Gyo Lee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Uptake of T-2307, a novel arylamidine, in Candida albicans
Hiroshi Nishikawa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Octenidine Dihydrochloride, a Modern Antiseptic for Skin, Mucous Membranes and Wounds
N. -O. Huebner et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2010)
Candida haemulonii and Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features
Mi-Na Kim et al.
CLINICAL INFECTIOUS DISEASES (2009)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Candida auris sp nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital
Kazuo Satoh et al.
MICROBIOLOGY AND IMMUNOLOGY (2009)
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine
Junichi Mitsuyama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Candida albicans cell wall proteins
W. LaJean Chaffin
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
分享论文
